Andreadou I, Iliodromitis EK, Koufaki M, Farmakis D, Tsotinis A, Kremastinos DT. Alternative pharmacological interventions that limit myocardial infarction. Curr Med Chem. 2008;15:1304–13.

Xin W, Yang X, Rich TC, Krieg T, Barrington R, Cohen MV, et al. All preconditioning-related G protein-coupled receptors can be demonstrated in the rabbit cardiomyocyte. J Cardiovasc Pharmacol Ther. 2012;17:190–8.PubMedCentralPubMed

Kin H, Zhao ZQ, Sun HY, Wang NP, Corvera JS, Halkos ME, et al. Postconditioning attenuates myocardial ischemia-reperfusion injury by inhibiting events in the early minutes of reperfusion. Cardiovasc Res. 2004;62:74–85.PubMed

Methner C, Schmidt K, Cohen MV, Downey JM, Krieg T. Both A2A and A2B adenosine receptors at reperfusion are necessary to reduce infarct size in mouse hearts. Am J Physiol Heart Circ Physiol. 2010;299:H1262–4.PubMedCentralPubMed

Philipp S, Yang XM, Cui L, Davis AM, Downey JM, Cohen MV. Postconditioning protects rabbit hearts through a protein kinase C-adenosine A2B receptor cascade. Cardiovasc Res. 2006;70:308–14.PubMed

Liu Y, Yang X, Yang XM, Walker S, Förster K, Cohen MV, et al. AMP579 is revealed to be a potent A2B-adenosine receptor agonist in human 293 cells and rabbit hearts. Basic Res Cardiol. 2010;105:129–37.PubMedCentralPubMed

Simkhovich BZ, Przyklenk K, Kloner RA. Role of protein kinase C in ischemic “conditioning”: from first evidence to current perspectives. J Cardiovasc Pharmacol Ther. 2013;18:525–32.PubMed

Hausenloy DJ, Tsang A, Mocanu MM, Yellon DM. Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. Am J Physiol. 2004;288:H971–6.

Gross ER, Gross GJ. Ligand triggers of classical preconditioning and postconditioning. Cardiovasc Res. 2006;70:212–21.PubMed

Baumgarten CR, Linz W, Kunkel G, Scholkens BA, Wiemer G. Ramiprilat increases bradykinin outflow from isolated hearts of rat. Br J Pharmacol. 1993;108:293–5.PubMedCentralPubMed

Marceau F, Hess JF, Bachvarov DR. The B1 receptors for kinins. Pharmacol Rev. 1998;50:357–86.PubMed

Yang XP, Liu YH, Scicli GM, Webb CR, Carretero OA. Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats. Hypertension. 1997;30:735–40.PubMed

Xu J, Carretero OA, Sun Y, Shesely EG, Rhaleb NE, Liu YH, et al. Role of the B1 kinin receptor in the regulation of cardiac function and remodeling after myocardial infarction. Hypertension. 2005;45:747–53.PubMed

Romano MA, Seymour EM, Berry JA, McNish RA, Bolling SF. Relative contribution of endogenous opioids to myocardial ischemic tolerance. J Surg Res. 2004;118:32–7.PubMed

Gross ER, Hsu AK, Gross GJ. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res. 2004;94:960–6.PubMed

Gross ER, Hsu AK, Gross GJ. Acute aspirin treatment abolishes, whereas acute ibuprofen treatment enhances morphine-induced cardioprotection: role of 12-lipoxygenase. J Pharmacol Exp Ther. 2004;310:185–91.PubMed

Gross ER, Peart JN, Hsu AK, Auchampach JA, Gross GJ. Extending the cardioprotective window using a novel delta-opioid agonist fentanyl isothiocyanate via the PI3-kinase pathway. Am J Physiol Heart Circ Physiol. 2005;288:H2744–9.PubMed

Oldenburg O, Qin Q, Krieg T, Yang XM, Philipp S, Critz SD, et al. Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am J Physiol Heart Circ Physiol. 2004;286:H468–76.PubMed

Schulz R, Cohen MV, Behrends M, Downey JM, Heusch G. Signal transduction of ischemic preconditioning. Cardiovasc Res. 2001;52:181–98.PubMed

Skyschally A, Schulz R, Gres P, Korth H, Heusch G. Attenuation of ischemic preconditioning in pigs by scavenging of free oxyradicals with ascorbic acid. Am J Physiol Heart Circ Physiol. 2003;284:H698–703.PubMed

Steeves G, Singh N, Singal PK. Preconditioning and antioxidant defense against reperfusion injury. Ann N Y Acad Sci. 1994;723:116–27.PubMed

Pain T, Yang XM, Critz SD, Yue Y, Nakano A, Liu GS, et al. Opening of mitochondrial K_ATP channels triggers the preconditioned state by generating free radicals. Circ Res. 2000;15:460–6.

Forbes A, Steenbergen C, Murphy E. The protective effect of diazoxide is blocked by antioxidants. Circulation. 1999;100(Suppl I):I342.

Andreadou I, Iliodromitis EK, Mikros E, Bofilis E, Zoga A, Constantinou M, et al. Melatonin does not prevent the protection of ischemic preconditioning in vivo despite its antioxidant effect against oxidative stress. Free Radic Biol Med. 2004;37:500–10.PubMed

Andreadou I, Iliodromitis EK, Tsovolas K, Aggeli IK, Zoga A, Gaitanaki C, et al. Acute administration of vitamin E triggers preconditioning via K(ATP) channels and cyclic-GMP without inhibiting lipid peroxidation. Free Radic Biol Med. 2006;41:1092–9.PubMed

Tsovolas K, Iliodromitis EK, Andreadou I, Zoga A, Demopoulou M, Iliodromitis KE, et al. Acute administration of vitamin C abrogates protection from ischemic preconditioning in rabbits. Pharmacol Res. 2008;57:283–9.PubMed

Andreadou I, Iliodromitis EK, Farmakis D, Kremastinos DT. To prevent, protect and save the ischemic heart: antioxidants revisited. Expert Opin Ther Targets. 2009;13:945–56.PubMed

Penna C, Mancardi D, Rastaldo R, Pagliaro P. Cardioprotection: a radical view Free radicals in pre and postconditioning. Biochim Biophys Acta. 2009;1787:781–93.PubMed

Kawabata KI, Netticadan T, Osada M, Tamura K, Dhalla NS. Mechanisms of ischemic preconditioning effects on Ca(2+) paradox-induced changes in heart. Am J Physiol Heart Circ Physiol. 2000;278:H1008–15.PubMed

Inserte J, Barba I, Hernando V, Abellán A, Ruiz-Meana M, Rodríguez-Sinovas A, et al. Effect of acidic reperfusion on prolongation of intracellular acidosis and myocardial salvage. Cardiovasc Res. 2008;77:782–90.PubMed

Javadov S, Karmazyn M. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem. 2007;20:1–22.PubMed